PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 223 filers reported holding PDL BIOPHARMA INC in Q4 2013. The put-call ratio across all filers is 0.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $6,166,000 | -15.0% | 1,957,423 | -21.5% | 0.00% | -33.3% |
| Q2 2020 | $7,256,000 | -19.2% | 2,493,332 | -21.7% | 0.00% | -25.0% |
| Q1 2020 | $8,978,000 | -7.8% | 3,183,678 | +6.1% | 0.00% | 0.0% |
| Q4 2019 | $9,739,000 | +50.3% | 3,001,136 | +0.0% | 0.00% | +33.3% |
| Q3 2019 | $6,480,000 | -31.4% | 3,000,284 | -0.2% | 0.00% | -25.0% |
| Q2 2019 | $9,443,000 | +0.8% | 3,007,552 | +19.4% | 0.00% | -20.0% |
| Q1 2019 | $9,366,000 | -24.4% | 2,517,835 | -41.1% | 0.01% | -28.6% |
| Q4 2018 | $12,394,000 | +6.2% | 4,273,630 | -3.7% | 0.01% | +40.0% |
| Q3 2018 | $11,668,000 | +39.4% | 4,436,511 | +24.0% | 0.01% | +25.0% |
| Q2 2018 | $8,371,000 | +74.7% | 3,577,987 | +119.5% | 0.00% | +33.3% |
| Q1 2018 | $4,793,000 | +481.7% | 1,630,306 | +570.5% | 0.00% | +200.0% |
| Q3 2017 | $824,000 | -90.9% | 243,160 | -93.4% | 0.00% | -87.5% |
| Q2 2017 | $9,090,000 | -27.6% | 3,680,069 | -33.4% | 0.01% | -27.3% |
| Q1 2017 | $12,549,000 | +92.1% | 5,528,172 | +79.4% | 0.01% | +83.3% |
| Q4 2016 | $6,532,000 | +1729.7% | 3,081,366 | +2799.2% | 0.01% | – |
| Q3 2016 | $357,000 | +117.7% | 106,282 | +103.5% | 0.00% | – |
| Q2 2016 | $164,000 | +127.8% | 52,228 | +140.5% | 0.00% | – |
| Q1 2016 | $72,000 | -96.4% | 21,714 | -96.1% | 0.00% | -100.0% |
| Q4 2015 | $1,978,000 | +36.9% | 558,804 | +94.6% | 0.00% | +100.0% |
| Q3 2015 | $1,445,000 | +10221.4% | 287,220 | +13435.3% | 0.00% | – |
| Q2 2015 | $14,000 | -99.7% | 2,122 | -99.6% | 0.00% | -100.0% |
| Q1 2015 | $4,036,000 | +334.9% | 573,661 | +376.3% | 0.00% | +300.0% |
| Q4 2014 | $928,000 | +80.9% | 120,451 | +75.5% | 0.00% | 0.0% |
| Q3 2014 | $513,000 | +342.2% | 68,647 | +473.1% | 0.00% | – |
| Q2 2014 | $116,000 | -87.0% | 11,979 | -88.8% | 0.00% | -100.0% |
| Q1 2014 | $892,000 | -90.0% | 107,261 | -89.8% | 0.00% | -91.7% |
| Q4 2013 | $8,876,000 | +10.4% | 1,051,651 | +4.2% | 0.01% | 0.0% |
| Q3 2013 | $8,041,000 | -7.3% | 1,008,941 | -10.2% | 0.01% | -20.0% |
| Q2 2013 | $8,676,000 | – | 1,123,806 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nine Chapters Capital Management LLC | 119,700 | $254,000 | 0.43% |
| GSA CAPITAL PARTNERS LLP | 1,587,756 | $3,366,000 | 0.20% |
| AMERICAFIRST CAPITAL MANAGEMENT, LLC | 60,901 | $129,110,000 | 0.14% |
| Acrospire Investment Management LLC | 129,480 | $274,000 | 0.11% |
| SECOR Capital Advisors, LP | 410,323 | $870,000 | 0.11% |
| RBF Capital, LLC | 251,421 | $540,000 | 0.08% |
| Park West Asset Management LLC | 400,000 | $848,000 | 0.07% |
| MACKENZIE FINANCIAL CORP | 4,687,825 | $9,938,000 | 0.06% |
| CIGNA INVESTMENTS INC /NEW | 261,533 | $554,000,000 | 0.06% |
| ACADIAN ASSET MANAGEMENT LLC | 5,503,285 | $11,665,000 | 0.06% |